Primary Antibodies Market 2021 Research and New Innovations in Keyplayers Abcam, BD, Santa Cruz Biotechnology, Sigma Aldrich Corporation, Thermo Fisher Scientific, Bio-Rad, R&D Systems, MBL, CST

Primary antibodies are immunoglobulins that bind to a specific antigen of interest and are typically unconjugated. These antibodies find application in detection of biomarkers for diseases such as cancer, diabetes, Parkinson’s, and Alzheimer’s disease. Depending on the source of development, primary antibodies can be monoclonal or polyclonal in type.

Inquire for a sample copy of this report @ https://www.stratagemmarketinsights.com/sample/9094

Increasing prevalence of cancer is expected to boost growth of EMEA primary antibodies market over the forecast period. For instance, according to the World Health Organization, the number of new cancer cases diagnosed per year in Africa is expected to grow from over 1 million in 2018 to over 2.1 million in 2040. Moreover, R&D breast cancer therapy is also expected to aid in growth of the market. For instance, in December 2018, researchers from Manisa Celal Bayar University, in the study ‘Cyclophosphamide Inhibits PI3K/AKT/mTOR Signaling Pathway in Mice Kidneys’ stained the tissues via indirect immunohistochemistry with PI3K, AKT and mTOR primary antibodies in order to show the effect of cyclophosphamide in kidney tissue.

High incidence of diabetes is expected to contribute to growth of EMEA primary antibodies market over the forecast period. For instance, according to the International Diabetes Federation, the number of people with diabetes in Africa is expected to increase in 143% by 2045 compared to 2019. Moreover, increasing investment in cancer detection is also expected to aid in growth of the market. For instance, in September 2019, Kheiron Medical Technologies, announced a US$ 22 million Series A round for early breast cancer detection for women worldwide.

Major players in the market are focused on adopting partnership and collaboration strategies to expand their product portfolio. For instance, in February 2020, StressMarq Biosciences, a supplier of primary antibodies, antibody conjugates, proteins, immunoassay kits and small molecules, collaborated with, Cellectricon, a company focused on advancing drug discovery, for the development of next-generation reagents and assays for neurodegenerative disease research.

Major players in the market are also focused on product development to expand their product portfolio. For instance, In September 2019, Biocare Medical, LLC launched a new mouse monoclonal antibody, p16 INK4a, for in vitro diagnostic use in the qualitative identification of the p16 INK4a protein by immunohistochemistry in formalin-fixed paraffin-embedded human tissues.

Get Offer in This Report- https://www.stratagemmarketinsights.com/discount/9094

Key Takeaways

Increasing prevalence of cancer is expected to augment growth of EMEA primary antibodies market over the forecast period
Investment in cancer detection is also expected to aid in growth of the market

Major players operating in EMEA primary antibodies market include, Abcam, BD, Santa Cruz Biotechnology, Sigma Aldrich Corporation, Thermo Fisher Scientific, Bio-Rad, R&D Systems, MBL, CST, Merk, Novus Biologicals, PeproTech, Cayman, AbMax Biotechnology, MABTech, KPL, and Abnova
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Primary Antibodies for these regions, from 2014 to 2025 (forecast)

➣ Europe: Germany, France, UK, Russia, Italy and Benelux;
➣ Middle East: Saudi Arabia, Israel, UAE and Iran;
➣ Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Primary Antibodies market competition by top manufacturers/players, with Primary Antibodies sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

➣ Abcam
➣ BD
➣ Santa Cruz Biotechnology
➣ Sigma Aldrich Corporation
➣ Thermo Fisher Scientific
➣ Bio-Rad
➣ R&D Systems
➣ MBL
➣ CST
➣ Merk
➣ Novus Biologicals
➣ PeproTech
➣ Cayman
➣ AbMax Biotechnology
➣ MABTech
➣ KPL
➣ Abnova

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

➣ Human
➣ Animal

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Primary Antibodies for each application, including

➣ ELISA
➣ Western Blot
➣ Immunostaining
➣ Immunohistochemistry
➣ Immunocytochemistry
➣ Other

Buy Now-
https://www.stratagemmarketinsights.com/cart/9094

**NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Us:
Mr. Shah
Stratagem Market Insights
Tel: US +1 415 871 0703 / JAPAN +81-50-5539-1737
Email: sales@stratagemmarketinsights.com
Explore By- SK

About Stratagem Market Insights:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with an cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.

This release was published on openPR.